The Cognitive Diagnostics Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The size of the cognitive diagnostics market has seen significant expansion recently. The market increased from $5.07 billion in 2024 and is projected to reach $6.25 billion in 2025, with a compound annual growth rate (CAGR) of 23.1%.
The Cognitive Diagnostics Global Market is projected to reach a market size of $14.25 billion by 2029, growing at a compound annual growth rate (CAGR) of 22.9%.
Download Your Free Sample of the 2025 Cognitive Diagnostics Market Report and Uncover Key Trends Now!The key drivers in the cognitive diagnostics market are:
• Growing adoption of digital health technologies and development of advanced biomarkers
• Increased focus on early and preventative diagnostics paired with the rising prevalence of neurodegenerative diseases
• Expansion of telemedicine, remote monitoring, and an increased investment in research and development
• Growing healthcare expenditure, alongside the integration of AI and big data analytics in the industry.
The cognitive diagnosticsmarket covered in this report is segmented –
1) By Diagnosis: Brain Imaging Tests, Laboratory Testing, Mental Status Testing, Rapid Home Screening Tests, Neuropsychological Testing, Electroencephalogram (EEG), Cognitive Function And Behavioral Tests, Neuropsychiatric Inventory Questionnaire (NPI-Q)
2) By Indication: Alzheimer’s Disease, Attention Deficit Or Hyperactivity Disorder, Dementia, Epilepsy-Related Cognitive Dysfunction, Mild Cognitive Impairment, Parkinson’s Disease-Related Cognitive Dysfunction, Stroke-Related Cognitive Dysfunction, Traumatic Brain Injury, Other Indications
3) By End User: Hospitals, Neurology Clinics, Cognitive Behavioral Therapy Centers, Rehabilitation Centers, Academic And Research Institutes, Diagnostic Imaging Centers, Home Care Settings
The key trends in the cognitive diagnostics market are:
• Adoption of digital health technologies and focus on early and preventative diagnostics will shape the future of the cognitive diagnostics market.
• Integration of AI and big data analytics is an emerging trend in the market.
• Use of wearable devices for cognitive monitoring and advances in biomarker discovery are gaining traction.
• The market will be greatly impacted by the increase in personalized and precision medicine and the rise of remote and telehealth diagnostics.
Major companies in the cognitive diagnostics market are:
• Cogstate Ltd.
• Viz.ai
• Redcliffe Labs
• Mind Maze
• Neurocare Group AG
• Pathway Genomics
• Diadem srl
• Cambridge Cognition Ltd.
• Posit Science Corporation
• Anderson Diagnostics & Labs
• Altoida AG
• BrainScope Company Inc.
• Neurotrack Technologies Inc.
• Cognetivity Neurosciences Ltd.
• BrainCheck
• Cyclops MedTech Pvt Ltd
• Twill Inc.
• CN Diagnostics
• Savonix Inc.
• Cognivue Inc.
• NeuroCog Trials
• Pearson Clinical
• Re:Cognition Health
• CogniSense
• The Neuropsychology Consultants
North America was the largest region in the cognitive diagnostics market in 2024